Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 11 | $1,869,915 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Nov 2022 16:20 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO & Secretary | 18 Nov 2022 | Sale | 722 | 5.44 | 3,928 | D |
23 Feb 2023 17:41 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 17 Feb 2023 | Sale | 4,954 | 7.66 | 37,948 | D |
19 May 2023 21:19 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 18 May 2023 | Sale | 4,037 | 10.1444 | 40,953 | D |
10 Jun 2024 18:42 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 07 Jun 2024 | Sale | 7,465 | 11.5296 | 86,068 | D |
10 Sep 2024 20:31 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 09 Sep 2024 | Sale | 7,352 | 12.1901 | 89,622 | D |
21 Nov 2023 16:31 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 20 Nov 2023 | Sale | 13,008 | 8.2293 | 107,047 | D |
21 Aug 2023 20:05 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 18 Aug 2023 | Sale | 13,067 | 10.7287 | 140,192 | D |
21 Aug 2024 21:25 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 19 Aug 2024 | Sale | 14,215 | 12.0133 | 170,769 | D |
21 May 2024 17:57 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 20 May 2024 | Sale | 21,959 | 11.7645 | 258,337 | D |
21 Feb 2024 21:46 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO | 20 Feb 2024 | Sale | 22,802 | 14.1148 | 321,846 | D |
16 Feb 2024 16:21 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO | 14 Feb 2024 | Sale | 40,855 | 15.0093 | 613,205 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)